GEVA Share Price

Open 236.64 Change Price %
High 239.20 1 Day 2.80 1.19
Low 236.43 1 Week 0.00 0.00
Close 238.60 1 Month 0.00 0.00
Volume 2146081 1 Year 0.00 0.00
52 Week High 3.40
52 Week Low 1.81
GEVA Important Levels
Resistance 2 241.17
Resistance 1 240.11
Pivot 238.08
Support 1 237.09
Support 2 236.03
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Synageva BioPharma Corp. (NASDAQ: GEVA)

GEVA Technical Analysis 5
As on 22nd Jun 2015 GEVA Share Price closed @ 238.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 105.91 & Strong Buy for SHORT-TERM with Stoploss of 171.24 we also expect STOCK to react on Following IMPORTANT LEVELS.
GEVA Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
GEVA Other Details
Segment EQ
Market Capital 1037002112.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.synageva.com
GEVA Address
GEVA
33 Hayden Avenue
Lexington, MA 02421
United States
Phone: 781-357-9900
Fax: 781-357-9901
GEVA Latest News
Alexion buys Lexington rare drug maker Synageva for $8.4B   Boston Business Journal (blog)   - 23rd Jun 15
Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC ...   PR Newswire (press release)   - 05th Jun 15
Synageva Biopharma Corp (GEVA) Stock Price Surges 115% On Alexion ...   International Business Times   - 07th May 15
Synageva BioPharma Reports First Quarter 2015 Financial Results and Provides ...   PR Newswire (press release)   - 30th Apr 15
Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL ...   PR Newswire (press release)   - 30th Mar 15
Synageva BioPharma Reports 2014 Full Year Financial Results   PR Newswire (press release)   - 27th Feb 15
Synageva BioPharma To Present At The Cowen and Company Health Care Conference   PR Newswire (press release)   - 25th Feb 15
Synageva BioPharma Announces Dosing Of Patients Commenced With SBC-103 In ...   PR Newswire (press release)   - 26th Jan 15
Synageva BioPharma Announces New Pipeline Programs And Other Company Progress   PR Newswire (press release)   - 05th Jan 15
Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer   PR Newswire (press release)   - 22nd Sep 14
Interactive Technical Analysis Chart Synageva BioPharma Corp. ( GEVA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Synageva BioPharma Corp.
GEVA Business Profile
GEVA profile